Sorted By:

Relevance


Director – Federal Advocacy

PhRMA  |  PhRMA Career

We are committed to the growth and development of our team members and offer many learning opportunities such as tuition reimbursement at both the undergraduate and graduate levels, industry on-site and off-site training, PhRMAcademy lunch and learn sessions, presentation skills, performance management and other management/professional develop programs. 
https://www.phrma.org

Study highlights negative impact of Canada's promise doctrine on R and D investment

PhRMA  |  Blog Post

For more information on Canada’s promise doctrine and its overall approach to IP, go to PatentsProtect.org.
http://catalyst.phrma.org/study-highlights-negative-impact-of-canadas-promise-doctrine-on-rd-investment

Higher deductibles and more dissatisfaction with health plans according to new poll

PhRMA  |  Blog Post

Learn more about this and other solutions here.
http://catalyst.phrma.org/new-poll-finds-less-satisfaction-with-coverage-due-to-rising-deductibles

HIV/AIDS: Then & Now

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/hiv/aids-then-and-now1

The Pacira Case Study: Patients are better served when health care professionals have the most accurate and up-to-date medical information

PhRMA  |  Blog Post

It is critical to modernize the FDA’s regulatory framework not only to make more comprehensive and up-to-date information available to health care providers and payers, but also to eliminate any confusion resulting from the recent and ongoing legal proceedings and adhere to the rulings in cases such as Caronia and Amarin.
http://catalyst.phrma.org/the-pacira-case-study-patients-are-better-served-when-health-care-professionals-have-the-most-accurate-and-up-to-date-medical-information

Medicare Monday Then & Now: Coverage

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/medicare-monday-then-and-now-coverage

Clarity around anti-kickback statute needed to promote innovative payment arrangements

PhRMA  |  Blog Post

Providing clear safe harbor protection to RBCs can encourage the uptake of these innovative payment arrangements and help advance our movement toward a health care system that better recognizes value.
http://catalyst.phrma.org/clarity-around-anti-kickback-statute

About

PhRMA  |  From PhRMA

New medicines are an integral part of the health care system, providing doctors and patients with safe and effective treatment options, and improving quality of life.
https://www.phrma.org/about

PhRMA Statement on Industry Support of Medical Education

PhRMA  |  Press Release

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-statement-on-industry-support-of-medical-education

I Am Research. Progress. Hope.

PhRMA  |  Video

Hope” initiative provides an opportunity for scientists working in drug discovery and development at America's biopharmaceutical companies to showcase their heroic and exciting work to younger generations while at the same time sharing what they do outside of work for fun.
https://www.phrma.org

PhRMA Statement on Industry Support of Medical Associations

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-industry-support-of-medical-associations

Medicare Part D: Then & Now

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/medicare-part-d-then-and-now

PhRMA Recognizes 2016 Research & Hope Award Recipients

PhRMA  |  Press Release

Pain Foundation and Vasculitis Foundation.
https://www.phrma.org/press-release/phrma-recognizes-2016-research-and-hope-award-recipients

PhRMA Recognizes 2016 Research & Hope Award Recipients

PhRMA  |  From PhRMA

Pain Foundation and Vasculitis Foundation.
https://www.phrma.org/media/phrma-recognizes-2016-research-and-hope-award-recipients

Medicines in Development for Leukemia & Lymphoma 2015 Report

PhRMA  |  Report

Major types of blood cancers include leukemia, lymphoma and myeloma.
https://www.phrma.org/report/medicines-in-development-for-leukemia-and-lymphoma-2015-report

ICYMI: Why 2017 medicine approvals matter

PhRMA  |  Blog Post

While medicine approval numbers ebb and flow each year, this achievement highlights the FDA and Commissioner Gottlieb’s commitment to providing patients with access to new medicines through the implementation of PDUFA VI, BSUFA II and the 21st Century Cures Act.
http://catalyst.phrma.org/icymi-2017-medicine-approvals-matter

Brain Cancer: Research Brings Hope to a Difficult Disease

PhRMA  |  Graphic

Many potential drugs to treat brain cancer did not make it through the rigorous clinical trials process in recent years but those unsuccessful attempts are paving the way for the new medicines....
https://www.phrma.org/graphic/brain-cancer-research-brings-hope-to-a-difficult-disease

Video: PhRMA CEO discusses medicine costs with CNBC's Squawk Box

PhRMA  |  Blog Post

Ubl joined Squawk Box this morning to put medicine costs and spending in context, the biopharmaceutical supply chain and policy solutions to address cost concerns and continue U.S. leadership in medical innovation.
http://catalyst.phrma.org/video-phrma-ceo-discusses-medicine-costs-with-cnbcs-squawk-box

PhRMA Statement on Trump Opioids Announcement

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-statement-on-trump-opioids-announcement

PhRMA Special 301 Submission 2017

PhRMA  |  Policy Paper

Encouraging and fostering innovation and protecting the IP of U.S.
https://www.phrma.org/phrma-special-301-submission

PhRMA Statement Following Meeting With President Trump

PhRMA  |  Press Release

"We look forward to working with the administration and Congress to advance solutions that promote economic growth and job creation and create a more competitive health care marketplace."
https://www.phrma.org/press-release/phrma-statement-following-meeting-with-president-trump

Comments of the Pharmaceutical Research and Manufacturers of America on the PTO’s Request for Comments on a Proposed Pilot Program Exploring an Alternative Approach to Institution Decisions in Post Grant Administrative Reviews

PhRMA  |  Speeches & Communication

The U.S. biopharmaceutical sector supports a total of 3.4 million jobs throughout the economy, and directly employs more than 810,000 Americans.
https://www.phrma.org/public-communication/comments-of-the-pharmaceutical-research-and-manufacturers-of-america-on-the-pto-s-request-for-comments-on-a-proposed-pilot-program-exploring-an-alternative-approach-to-institution-decisions-in-post-grant-administrative-revi

PhRMA Member Company R&D Investment

Chartpack  |  From Our Network

The pharmaceutical industry is one of the most research-intensive industries in the U.S. and invests as much as five times more in R&D, relative to their sales, than the average manufacturing firm in the U.S.
http://chartpack.phrma.org/biophrma-chartpack/research-and-development/phrma-member-company-randd-investment

Hepatitis C: Myths & Facts

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/hepatitis-c-myths-and-facts

Chart Pack: Biopharmaceuticals in Perspective

PhRMA  |  Report

PhRMA hopes this publication provides useful context for discussions regarding the role of medicines and the US economy.
https://www.phrma.org

You have reviewed the first 425 results out of 2506. Each page contains 25 results. You're on page 17.

prev 13 14 15 16 17 18 next